Dr. Mechoulam’s latest discovery is called EPM301, or cannabidiolic acid methyl ester, also known as CBDa. EPM stands for Endless Potential Molecules, and there are now around 14 patented molecules that are being tested on humans with the US FDAs guidance. The first targets of EPM are psoriasis and inflammatory bowel disease (IBD), which are notoriously difficult to treat.
Slapwoods is announcing its first-ever official collaboration with DJ Screw, the late Houston legend whose…
It could be so easy to believe that cannabis culture is something that has been…
Modern cultivation techniques and spiritual practices collide with Pink Boost Goddess on our next Legendary…
Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…
This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…
How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…